These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26290450)

  • 41. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
    Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer.
    Choi TG; Nguyen MN; Kim J; Jo YH; Jang M; Nguyen NNY; Yun HR; Choe W; Kang I; Ha J; Tang DG; Kim SS
    J Pathol; 2018 Sep; 246(1):115-126. PubMed ID: 29876924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.
    Di Conza G; Trusso Cafarello S; Loroch S; Mennerich D; Deschoemaeker S; Di Matteo M; Ehling M; Gevaert K; Prenen H; Zahedi RP; Sickmann A; Kietzmann T; Moretti F; Mazzone M
    Cell Rep; 2017 Feb; 18(7):1699-1712. PubMed ID: 28199842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53.
    Vidimar V; Licona C; Cerón-Camacho R; Guerin E; Coliat P; Venkatasamy A; Ali M; Guenot D; Le Lagadec R; Jung AC; Freund JN; Pfeffer M; Mellitzer G; Sava G; Gaiddon C
    Cancer Lett; 2019 Jan; 440-441():145-155. PubMed ID: 30339780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
    Ramos H; Soares MIL; Silva J; Raimundo L; Calheiros J; Gomes C; Reis F; Monteiro FA; Nunes C; Reis S; Bosco B; Piazza S; Domingues L; Chlapek P; Vlcek P; Fabian P; Rajado AT; Carvalho ATP; Veselska R; Inga A; Pinho E Melo TMVD; Saraiva L
    Cell Rep; 2021 Apr; 35(2):108982. PubMed ID: 33852837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia Promotes Synergy between Mitomycin C and Bortezomib through a Coordinated Process of Bcl-xL Phosphorylation and Mitochondrial Translocation of p53.
    Song X; Dilly AK; Choudry HA; Bartlett DL; Kwon YT; Lee YJ
    Mol Cancer Res; 2015 Dec; 13(12):1533-43. PubMed ID: 26354682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The DpdtbA induced EMT inhibition in gastric cancer cell lines was through ferritinophagy-mediated activation of p53 and PHD2/hif-1α pathway.
    Guan D; Li C; Li Y; Li Y; Wang G; Gao F; Li C
    J Inorg Biochem; 2021 May; 218():111413. PubMed ID: 33713969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer.
    Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J
    J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels.
    Giovannetti E; Backus HH; Wouters D; Ferreira CG; van Houten VM; Brakenhoff RH; Poupon MF; Azzarello A; Pinedo HM; Peters GJ
    Br J Cancer; 2007 Mar; 96(5):769-75. PubMed ID: 17339891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2.
    Nakayama K; Gazdoiu S; Abraham R; Pan ZQ; Ronai Z
    Biochem J; 2007 Jan; 401(1):217-26. PubMed ID: 16958618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
    Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer.
    Li Z; Zhou W; Zhang Y; Sun W; Yung MMH; Sun J; Li J; Chen CW; Li Z; Meng Y; Chai J; Zhou Y; Liu SS; Cheung ANY; Ngan HYS; Chan DW; Zheng W; Zhu W
    Clin Cancer Res; 2019 Oct; 25(19):5947-5960. PubMed ID: 31285371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
    Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
    Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2.
    Kozlova N; Mennerich D; Samoylenko A; Dimova EY; Koivunen P; Biterova E; Richter K; Hassinen A; Kellokumpu S; Manninen A; Miinalainen I; Glumoff V; Ruddock L; Drobot LB; Kietzmann T
    Cancer Res; 2019 Aug; 79(16):4042-4056. PubMed ID: 31142511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response.
    Xie L; Pi X; Mishra A; Fong G; Peng J; Patterson C
    J Clin Invest; 2012 Aug; 122(8):2827-36. PubMed ID: 22797300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.
    Tominaga T; Iwahashi M; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Oku Y; Nasu T; Yamaue H
    Int J Cancer; 2010 Apr; 126(7):1691-701. PubMed ID: 19810096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma.
    Fu D; Pfannenstiel L; Demelash A; Phoon YP; Mayell C; Cabrera C; Liu C; Zhao J; Dermawan J; Patil D; DeVecchio J; Kalady M; Souers AJ; Phillips DC; Li X; Gastman B
    Cell Death Dis; 2022 Jan; 13(1):63. PubMed ID: 35042842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
    Huang KT; Mikeska T; Dobrovic A; Fox SB
    Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
    Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
    Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.